CY1122114T1 - Καταπινομενα δισκια ν-ακετυλοκυστεϊνης - Google Patents
Καταπινομενα δισκια ν-ακετυλοκυστεϊνηςInfo
- Publication number
- CY1122114T1 CY1122114T1 CY20191100404T CY191100404T CY1122114T1 CY 1122114 T1 CY1122114 T1 CY 1122114T1 CY 20191100404 T CY20191100404 T CY 20191100404T CY 191100404 T CY191100404 T CY 191100404T CY 1122114 T1 CY1122114 T1 CY 1122114T1
- Authority
- CY
- Cyprus
- Prior art keywords
- tablets
- acetylocysteine
- swallowed tablets
- swallowed
- acetylcysteine
- Prior art date
Links
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 abstract 2
- 229960004308 acetylcysteine Drugs 0.000 abstract 2
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 238000007906 compression Methods 0.000 abstract 1
- 230000006835 compression Effects 0.000 abstract 1
- 238000007908 dry granulation Methods 0.000 abstract 1
- 239000008187 granular material Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/12—Mucolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Η παρούσα εφεύρεση αναφέρεται σε καταπινόμενα δισκία που περιέχουν τουλάχιστον 80% κατά βάρος Ν-ακετυλοκυστεΐνη (NAC) και τουλάχιστον ένα φαρμακευτικώς αποδεκτό έκδοχο, συγκεκριμένα σε δισκία στα οποία απουσιάζει η θειώδης οσμή, τα οποία χαρακτηρίζονται από το ότι τα εν λόγω δισκία κατασκευάζονται χρησιμοποιώντας ένα κοκκώδες υλικό το οποίο παρασκευάζεται μέσω μιας διαδικασίας ξηρής κοκκιοποίησης του δραστικού συστατικού μόνου του, με το οποίο τα έκδοχα αναμειγνύονται πριν από τη συμπίεση.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000874A ITMI20130874A1 (it) | 2013-05-29 | 2013-05-29 | Compresse deglutibili di n-acetilcisteina |
PCT/EP2014/060950 WO2014191410A1 (en) | 2013-05-29 | 2014-05-27 | Swallowable n-acetylcysteine tablets |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1122114T1 true CY1122114T1 (el) | 2020-07-31 |
Family
ID=48748383
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20191100404T CY1122114T1 (el) | 2013-05-29 | 2019-04-11 | Καταπινομενα δισκια ν-ακετυλοκυστεϊνης |
Country Status (29)
Country | Link |
---|---|
US (1) | US9808427B2 (el) |
EP (1) | EP3003278B1 (el) |
JP (1) | JP6438013B2 (el) |
CN (1) | CN105228595B (el) |
AU (1) | AU2014273148B2 (el) |
BR (1) | BR112015029038B1 (el) |
CA (1) | CA2911474C (el) |
CY (1) | CY1122114T1 (el) |
DK (1) | DK3003278T3 (el) |
EA (1) | EA031856B1 (el) |
ES (1) | ES2721649T3 (el) |
HR (1) | HRP20190687T1 (el) |
HU (1) | HUE044880T2 (el) |
IL (1) | IL242439B (el) |
IT (1) | ITMI20130874A1 (el) |
LT (1) | LT3003278T (el) |
MX (1) | MX366917B (el) |
MY (1) | MY174005A (el) |
PE (1) | PE20160184A1 (el) |
PH (1) | PH12015502608A1 (el) |
PL (1) | PL3003278T3 (el) |
PT (1) | PT3003278T (el) |
RS (1) | RS58653B1 (el) |
SG (2) | SG11201509177VA (el) |
SI (1) | SI3003278T1 (el) |
TR (1) | TR201906101T4 (el) |
UA (1) | UA117829C2 (el) |
WO (1) | WO2014191410A1 (el) |
ZA (1) | ZA201508411B (el) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018108960A1 (en) | 2016-12-15 | 2018-06-21 | Zambon S.P.A. | N-acetylcysteine for use as antibacterial agent |
IT201700109080A1 (it) * | 2017-09-28 | 2019-03-28 | Neilos S R L | Composizione per la prevenzione e/o il trattamento delle affezioni delle vie respiratorie |
JP2021508316A (ja) * | 2017-11-02 | 2021-03-04 | ザンボン エス.ピー.エー.ZAMBON S.p.A. | サフィナミドを含む医薬組成物 |
US10288629B1 (en) * | 2017-12-19 | 2019-05-14 | Aeterna Zentaris, Inc. | Method of assessing growth hormone deficiency in humans by a macimorelin containing composition |
WO2019238647A1 (en) * | 2018-06-14 | 2019-12-19 | Poxel | Film-coated tablet comprising a triazine derivative for use in the treatment of diabetes |
IT201800007928A1 (it) * | 2018-08-07 | 2020-02-07 | Sofar Spa | Composizione contenente un agente mucolitico per il trattamento di ipersecrezione di muco e dispositivo per il suo dosaggio |
CN112843008A (zh) * | 2021-02-07 | 2021-05-28 | 广东赛康制药厂有限公司 | 一种乙酰半胱氨酸片及其制备方法 |
CN114886860B (zh) * | 2022-06-28 | 2023-04-25 | 山东达因海洋生物制药股份有限公司 | 一种乙酰半胱氨酸药物组合物及其制剂和制备工艺 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE59106133D1 (de) * | 1990-10-19 | 1995-09-07 | Spirig Ag | Feste, schnell-lösliche Arzneimittelzubereitung enthaltend S-(Carboxymethyl)-L-Cystein und/oder N-Acetylcystein. |
GB9305058D0 (en) * | 1993-03-12 | 1993-04-28 | Penn Pharm Ltd | Pharmaceutical compositions |
IT1311907B1 (it) | 1999-04-06 | 2002-03-20 | Zambon Spa | Compresse deglutibili ad alto contenuto di n-acetilcisteina. |
US6623754B2 (en) * | 2001-05-21 | 2003-09-23 | Noveon Ip Holdings Corp. | Dosage form of N-acetyl cysteine |
JP2003155232A (ja) * | 2001-09-07 | 2003-05-27 | Takeda Chem Ind Ltd | 不快な臭いが低減されたl−システイン配合固形製剤およびその製造方法 |
US20080139654A1 (en) * | 2006-12-09 | 2008-06-12 | Eric Mott Soderling | Acetaminophen compositions having minimized side effects including reduced hepatotoxicity |
IT1399492B1 (it) * | 2010-04-13 | 2013-04-19 | Alpex Pharma Sa | Composizioni farmaceutiche effervescenti contenenti n-acetilcisteina. |
EP2574333B1 (en) | 2011-09-27 | 2017-01-11 | Friulchem SpA | N-acetylcysteine effervescent tablet and its therapeutical applications |
-
2013
- 2013-05-29 IT IT000874A patent/ITMI20130874A1/it unknown
-
2014
- 2014-05-27 SI SI201431172T patent/SI3003278T1/sl unknown
- 2014-05-27 US US14/893,100 patent/US9808427B2/en active Active
- 2014-05-27 TR TR2019/06101T patent/TR201906101T4/tr unknown
- 2014-05-27 CN CN201480029563.1A patent/CN105228595B/zh active Active
- 2014-05-27 EA EA201592172A patent/EA031856B1/ru unknown
- 2014-05-27 LT LTEP14728495.4T patent/LT3003278T/lt unknown
- 2014-05-27 PE PE2015002421A patent/PE20160184A1/es active IP Right Grant
- 2014-05-27 JP JP2016516129A patent/JP6438013B2/ja active Active
- 2014-05-27 PT PT14728495T patent/PT3003278T/pt unknown
- 2014-05-27 PL PL14728495T patent/PL3003278T3/pl unknown
- 2014-05-27 WO PCT/EP2014/060950 patent/WO2014191410A1/en active Application Filing
- 2014-05-27 MX MX2015016130A patent/MX366917B/es active IP Right Grant
- 2014-05-27 RS RS20190507A patent/RS58653B1/sr unknown
- 2014-05-27 ES ES14728495T patent/ES2721649T3/es active Active
- 2014-05-27 DK DK14728495.4T patent/DK3003278T3/da active
- 2014-05-27 HU HUE14728495 patent/HUE044880T2/hu unknown
- 2014-05-27 SG SG11201509177VA patent/SG11201509177VA/en unknown
- 2014-05-27 SG SG10201709861YA patent/SG10201709861YA/en unknown
- 2014-05-27 EP EP14728495.4A patent/EP3003278B1/en active Active
- 2014-05-27 BR BR112015029038-8A patent/BR112015029038B1/pt active IP Right Grant
- 2014-05-27 AU AU2014273148A patent/AU2014273148B2/en active Active
- 2014-05-27 MY MYPI2015704193A patent/MY174005A/en unknown
- 2014-05-27 UA UAA201512351A patent/UA117829C2/uk unknown
- 2014-05-27 CA CA2911474A patent/CA2911474C/en active Active
-
2015
- 2015-11-04 IL IL242439A patent/IL242439B/en active IP Right Grant
- 2015-11-13 ZA ZA2015/08411A patent/ZA201508411B/en unknown
- 2015-11-23 PH PH12015502608A patent/PH12015502608A1/en unknown
-
2019
- 2019-04-11 HR HRP20190687TT patent/HRP20190687T1/hr unknown
- 2019-04-11 CY CY20191100404T patent/CY1122114T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1122114T1 (el) | Καταπινομενα δισκια ν-ακετυλοκυστεϊνης | |
CY1124007T1 (el) | Στοματικες δοσολογικες μορφες παρατεταμενης απελευθερωσης τοφασιτινιμπης | |
CY1122730T1 (el) | 1,2,4-τριαζολες ως διαμορφωτες πυρηνικης μεταφορας και χρησεις αυτων | |
CY1116698T1 (el) | Συνθεση περιεχοντας υπερ-μικρονοποιημενο παλμιτοϋλ-αιθανολαμιδιο | |
EA201692043A1 (ru) | Лекарственная форма иммунодепрессанта | |
EA201690810A1 (ru) | Мягкие пастилки, содержащие экстракт куркумы | |
EA201500245A1 (ru) | Твердый фармацевтический препарат, который содержит левотироксин | |
CY1123022T1 (el) | Σταθερες φαρμακευτικες συνθεσεις που περιεχουν σιταγλιπτινη υπο τη μορφη δισκιων αμεσης απελευθερωσης | |
PH12015500823A1 (en) | Modified release formulations for oprozomib | |
CY1122387T1 (el) | Διπλης χρησης δισκια στοματικης φαρμακευτικης συνθεσης θειικων αλατων και μεθοδοι χρησης αυτων | |
EA201591150A1 (ru) | Твердая единая форма с высоким содержанием фексофенадина и способ ее получения | |
ECSP12012121A (es) | Formulaciones farmacéuticas sólidas de ramipril y besilato de amlodipino y su preparación | |
UA113977C2 (xx) | Фармацевтична композиція з покращеною стабільністю | |
EA201890477A1 (ru) | Инкапсулированная композиция финголимода | |
BR112017019364A2 (pt) | dispersões sólidas | |
CL2016000183A1 (es) | Composición farmacéutica anti-tuberculosis estable en una forma de un comprimido redispersable que comprende gránulos de isoniazid y gránulos de rifapentina y su proceso de preparación | |
UY37518A (es) | Formas de dosificación de liberación modificada gastroretentivas para oprozomib y proceso para su fabricación | |
CY1121280T1 (el) | Χρηση της θυαζολοπυριμιδινονης για τη θεραπεια της φλεγμονωδους νοσου του εντερου | |
BR112013000870A2 (pt) | forma de dosagem farmacêutica oral em comprimidos | |
EA201800197A1 (ru) | Способ получения фармацевтической композиции в форме таблеток, содержащих в качестве действующего вещества абиратерона ацетат, и фармацевтическая композиция | |
CY1124264T1 (el) | Απο toy στοματος θεραπευτικος παραγοντας του θυρεοειδους | |
CY1122377T1 (el) | Αργινινη για χρηση στη θεραπεια και/ή προληψη οστεοαρθριτιδας | |
UA120295U (uk) | Лікарській засіб антитромбоцитарної дії | |
TR201722102A2 (tr) | Levodropropizin İçeren Farmasötik Bir Ürün | |
TR201619983A2 (tr) | Di̇klofenak ve eletri̇ptanin farmasöti̇k formülasyonlari |